Poly(ADP-Ribose) Polymerase Inhibitors

被引：1

作者：

Garon, Edward B. ^{[1
]}

Dubnett, Steven M. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Santa Monica, CA 90404 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期

关键词：

D O I：

10.1097/01.JTO.0000391363.10517.56

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：S455 / S456

页数：2

共 9 条

[1] ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models [J].

Donawho, Cherrie K. ;

Luo, Yan ;

Luo, Yanping ;

Penning, Thomas D. ;

Bauch, Joy L. ;

Bouska, Jennifer J. ;

Bontcheva-Diaz, Velitchka D. ;

Cox, Bryan F. ;

DeWeese, Theodore L. ;

Dillehay, Larry E. ;

Ferguson, Debra C. ;

Ghoreishi-Haack, Nayereh S. ;

Grimm, David R. ;

Guan, Ran ;

Han, Edward K. ;

Holley-Shanks, Rhonda R. ;

Hristov, Boris ;

Idler, Kenneth B. ;

Jarvis, Ken ;

Johnson, Eric F. ;

Kleinberg, Lawrence R. ;

Klinghofer, Vered ;

Lasko, Loren M. ;

Liu, Xuesong ;

Marsh, Kennan C. ;

McGonigal, Thomas P. ;

Meulbroek, Jonathan A. ;

Olson, Amanda M. ;

Palma, Joann P. ;

Rodriguez, Luis E. ;

Shi, Yan ;

Stavropoulos, Jason A. ;

Tsurutani, Alan C. ;

Zhu, Gui-Dong ;

Rosenberg, Saul H. ;

Giranda, Vincent L. ;

Frost, David J. .

CLINICAL CANCER RESEARCH, 2007, 13 (09) :2728-2737

[2] Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers. [J].

Fong, Peter C. ;

Boss, David S. ;

Yap, Timothy A. ;

Tutt, Andrew ;

Wu, Peijun ;

Mergui-Roelvink, Marja ;

Mortimer, Peter ;

Swaisland, Helen ;

Lau, Alan ;

O'Connor, Mark J. ;

Ashworth, Alan ;

Carmichael, James ;

Kaye, Stan B. ;

Schellens, Jan H. M. ;

de Bono, Johann S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :123-134

[3] DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy [J].

Olaussen, Ken A. ;

Dunant, Ariane ;

Fouret, Pierre ;

Brambilla, Elisabeth ;

Andre, Fabrice ;

Haddad, Vincent ;

Taranchon, Estelle ;

Filipits, Martin ;

Pirker, Robert ;

Popper, Helmut H. ;

Stahel, Rolf ;

Sabatier, Laure ;

Pignon, Jean-Pierre ;

Tursz, Thomas ;

Le Chevalier, Thierry ;

Soria, Jean-Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) :983-991

[4]

OSHAUGHNESSY J, 2009, SABCS 2009 SAN ANT T

[5] Phase I Study of the Poly (ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors [J].

Plummer, Ruth ;

Jones, Christopher ;

Middleton, Mark ;

Wilson, Richard ;

Evans, Jeffrey ;

Olsen, Anna ;

Curtin, Nicola ;

Boddy, Alan ;

McHugh, Peter ;

Newell, David ;

Harris, Adrian ;

Johnson, Patrick ;

Steinfeldt, Heidi ;

Dewji, Raz ;

Wang, Diane ;

Robson, Lesley ;

Calvert, Hilary .

CLINICAL CANCER RESEARCH, 2008, 14 (23) :7917-7923

[6]

Sequist LV, 2009, J CLIN ONCOL, V27

[7]

SIMON G, 2009, 13 WORLD C LUNG CANC

[8]

Simon G, 2007, J CLIN ONCOL, V25, P2741, DOI 10.1200/JCO.2006.08.2099

[9] ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel [J].

Wang, Lifeng ;

Wei, Jia ;

Qian, Xiaoping ;

Yin, Haitao ;

Zhao, Yang ;

Yu, Lixia ;

Wang, Tingting ;

Liu, Baorui .

BMC CANCER, 2008, 8 (1)

← 1 →